The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
NCT01413360 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2016-07-15
Summary
The investigators will evaluate the efficacy of high dose vitamin C in chronic hepatitis patients whose serum liver enzymes are elevated more than upper limit.
Conditions
- Chronic Hepatitis
- Chronic Hepatitis C
- Chronic Alcoholic Hepatitis
Interventions
- DRUG
-
High dose vitamin C
Vitamin C, 3g per day (tid), with meal, per oral with water 100mL
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jung-Hwan Yoon, M.D, Ph.D · Seoul National University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Chronic Hepatitis C and Insulin Resistance
NCT00707603 ·Status: COMPLETED
-
Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
NCT01909557 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs
NCT03897608 ·Status: UNKNOWN
-
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C
NCT03402165 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)
NCT02745132 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Hepatitis C Clearance on Insulin Resistance
NCT04457050 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
the Pulmonary Safety of Antihepatitis C Treatment
NCT04122066 ·Status: UNKNOWN
-
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
NCT03170076 ·Status: UNKNOWN
-
Metformin Therapy in HCV Infection
NCT02972723 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
NCT03268317 ·Status: UNKNOWN
-
Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy
NCT02469012 ·Status: UNKNOWN ·Phase: NA
-
High Dose Insulin Therapy to Improve Liver Function
NCT01271140 ·Status: UNKNOWN ·Phase: NA
-
Risk of HCC in Cirrhotic Patients Post DAAs Ttt
NCT03414554 ·Status: UNKNOWN
-
Screening for Chronic Hepatitis C Virus in Hospitalized Patients
NCT04437277 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C Treatment and Atherosclerosis
NCT00659256 ·Status: COMPLETED
-
Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial
NCT04330508 ·Status: COMPLETED
-
Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression
NCT00205075 ·Status: COMPLETED
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Chronic Hepatitis C and Disease Modelling
NCT03566563 ·Status: COMPLETED
-
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
NCT00788918 ·Status: COMPLETED ·Phase: NA
-
Metabolic Changes in Chronic HCV Patients Receiving DAAS
NCT04211844 ·Status: UNKNOWN
-
Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment
NCT01329952 ·Status: UNKNOWN
-
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
NCT03993925 ·Status: ACTIVE_NOT_RECRUITING
-
Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
NCT03508115 ·Status: COMPLETED